Abstract

BackgroundCytochrome P450 3A4 (CYP3A4) is the major cytochrome involved in metabolizing of >60% of all drugs used in humans. A number of allelic variations in CYP3A4 gene are known to affect catalytic activity including CYP3A4⁎4, CYP3A4⁎5 and CYP3A4⁎18. We investigated the frequencies of CYP3A4⁎4, CYP3A4⁎5 and CYP3A4⁎18 alleles in a Malaysian population. This will impact treatment of patients receiving drugs metabolized by these alleles. MethodsThe study was conducted in 121 healthy Malaysian volunteers. DNA was extracted from leucocytes and the 3 alleles were determined by PCR–RFLP. The PCR product was later digested with restriction enzymes BstMA I, BshV I and Hpa II. ResultsNo mutations were detected for CYP3A4⁎4 and CYP3A4⁎5 alleles. The frequency of the CYP3A4⁎18 allele in the Malaysian population is 2.1%. All 5 subjects with CYP3A4⁎18 mutations were found to be heterozygous. ConclusionThe present study describes polymorphisms of CYP3A4 among Malaysian subjects. Clinical relevance of these genetic variants in these healthy volunteers is under investigation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.